间氯苯基哌嗪
参考资料

1 2  Rotzinger S, Bourin M, Akimoto Y, Coutts RT, Baker GB. . Cellular and Molecular Neurobiology. August 1999, 19 (4): 427–442. PMID 10379419. S2CID 19585113. doi:10.1023/a:1006953923305.
↑  Schatzberg AF, Nemeroff CB. . American Psychiatric Pub. 2017: 460–. ISBN 978-1-58562-523-9.
↑  Bossong MG, Van Dijk JP, Niesink RJ. . Addiction Biology. December 2005, 10 (4): 321–323. PMID 16318952. S2CID 36169592. doi:10.1080/13556210500350794. （原始内容存档于2013-01-05）.
↑  Lecompte Y, Evrard I, Arditti J. . Therapie. 2006, 61 (6): 523–530. PMID 17348609. doi:10.2515/therapie:2006093 （法语）.
1 2  Bossong MG, Brunt TM, Van Dijk JP, Rigter SM, Hoek J, Goldschmidt HM, Niesink RJ. . Journal of Psychopharmacology. September 2010, 24 (9): 1395–1401. PMID 19304863. S2CID 11186375. doi:10.1177/0269881109102541.
↑  Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke H, Niesink RJ. . Addiction. December 2009, 104 (12): 2057–2066. PMID 19804461. doi:10.1111/j.1360-0443.2009.02707.x .
↑  World Health Organization.  (PDF).   [2021-01-12]. （原始内容存档 (PDF)于2022-09-01）.
↑  Tancer ME, Johanson CE. . Drug and Alcohol Dependence. December 2001, 65 (1): 97–101. PMID 11714594. doi:10.1016/s0376-8716(01)00146-6.
↑  Tancer M, Johanson CE. . Drug and Alcohol Dependence. October 2003, 72 (1): 33–44. PMID 14563541. doi:10.1016/S0376-8716(03)00172-8.
↑  Nelson DL, Lucaites VL, Wainscott DB, Glennon RA. . Naunyn-Schmiedeberg's Archives of Pharmacology. January 1999, 359 (1): 1–6. PMID 9933142. S2CID 20150858. doi:10.1007/pl00005315.
↑  Rajkumar R, Pandey DK, Mahesh R, Radha R. . European Journal of Pharmacology. April 2009, 608 (1–3): 32–41. PMID 19269287. doi:10.1016/j.ejphar.2009.02.041.
↑  Kennett GA, Whitton P, Shah K, Curzon G. . European Journal of Pharmacology. May 1989, 164 (3): 445–454. PMID 2767117. doi:10.1016/0014-2999(89)90252-5.
↑  Klein E, Zohar J, Geraci MF, Murphy DL, Uhde TW. . Biological Psychiatry. November 1991, 30 (10): 973–984  [2024-04-11]. PMID 1756202. S2CID 43010184. doi:10.1016/0006-3223(91)90119-7. （原始内容存档于2020-09-15）.
↑  Charney DS, Woods SW, Goodman WK, Heninger GR. . Psychopharmacology. 1987, 92 (1): 14–24. PMID 3110824. S2CID 43079787. doi:10.1007/bf00215473.
↑  Van Veen JF, Van der Wee NJ, Fiselier J, Van Vliet IM, Westenberg HG. . European Neuropsychopharmacology. October 2007, 17 (10): 637–642. PMID 17481859. S2CID 41601926. doi:10.1016/j.euroneuro.2007.03.005.
↑  van der Wee NJ, Fiselier J, van Megen HJ, Westenberg HG. . European Neuropsychopharmacology. October 2004, 14 (5): 413–417. PMID 15336303. S2CID 28987431. doi:10.1016/j.euroneuro.2004.01.001.
↑  Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB,  et al. . Archives of General Psychiatry. January 1992, 49 (1): 21–28. PMID 1728249. doi:10.1001/archpsyc.1992.01820010021003.
↑  Broocks A, Pigott TA, Hill JL, Canter S, Grady TA, L'Heureux F, Murphy DL. . Psychiatry Research. June 1998, 79 (1): 11–20  [2024-04-11]. PMID 9676822. S2CID 30339598. doi:10.1016/S0165-1781(98)00029-8. （原始内容存档于2020-09-15）.
↑  Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL. . Biological Psychiatry. March 1991, 29 (5): 418–426. PMID 2018816. S2CID 37648659. doi:10.1016/0006-3223(91)90264-M.
↑  Leone M, Attanasio A, Croci D, Filippini G, D'Amico D, Grazzi L,  et al. . Neurology. July 2000, 55 (1): 136–139. PMID 10891925. S2CID 27617431. doi:10.1212/wnl.55.1.136.
↑  Martin RS, Martin GR. . Cephalalgia. February 2001, 21 (1): 46–52. PMID 11298663. S2CID 8471836. doi:10.1046/j.1468-2982.2001.00157.x .
↑  Petkov VD, Belcheva S, Konstantinova E. . Methods and Findings in Experimental and Clinical Pharmacology. December 1995, 17 (10): 659–668. PMID 9053586.
↑  Kennett GA, Curzon G. . Psychopharmacology. 1988, 96 (1): 93–100. PMID 2906446. S2CID 21417374. doi:10.1007/BF02431539.
↑  Sargent PA, Sharpley AL, Williams C, Goodall EM, Cowen PJ. . Psychopharmacology. October 1997, 133 (3): 309–312. PMID 9361339. S2CID 7125577. doi:10.1007/s002130050407. （原始内容存档于2002-01-12）.
↑  Hayashi A, Suzuki M, Sasamata M, Miyata K. . Psychopharmacology. March 2005, 178 (2–3): 241–249. PMID 15719229. S2CID 7580231. doi:10.1007/s00213-004-2019-z.
↑  Halford JC, Harrold JA, Boyland EJ, Lawton CL, Blundell JE. . Drugs. 2007, 67 (1): 27–55. PMID 17209663. S2CID 46972692. doi:10.2165/00003495-200767010-00004.